Trial intelligence / Profile preview

Circadin in Insomnia Patients with Low Endogenous Melatonin

NCT00397189Phase 3Completed

Sponsor
Neurim Pharmaceuticals
Start
Oct 2006
Primary completion
Dec 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of melatonin in Insomnia, sponsored by Neurim Pharmaceuticals. Started Oct 2006; status: completed.

02

Drugs

melatonin
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT00397189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00397189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call